The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
now it's interesting when you talk about today's triple therapy which is way more efficacious two of those three drugs are very expensive yes the S to2 Inhibitors are very expensive and the modern day gen 3 gen Gen 4 and soon we'll have a Gen 5 gop1 they're very pricey they're very $1,000 a month for the yeah
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.